Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches.

Grand'Maison F, Yeung M, Morrow SA, Lee L, Emond F, Ward BJ, Laneuville P, Schecter R.

Neural Regen Res. 2018 Nov;13(11):1871-1874. doi: 10.4103/1673-5374.239432. Review.

2.

Parp3 promotes long-range end joining in murine cells.

Layer JV, Cleary JP, Brown AJ, Stevenson KE, Morrow SN, Van Scoyk A, Blasco RB, Karaca E, Meng FL, Frock RL, Tivey T, Kim S, Fuchs H, Chiarle R, Alt FW, Roberts SA, Weinstock DM, Day TA.

Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):10076-10081. doi: 10.1073/pnas.1801591115. Epub 2018 Sep 13.

PMID:
30213852
3.

Depressive Symptoms Are Associated With More Negative Functional Outcomes Than Anxiety Symptoms in Persons With Multiple Sclerosis.

Gill S, Santo J, Blair M, Morrow SA.

J Neuropsychiatry Clin Neurosci. 2018 Sep 6:appineuropsych18010011. doi: 10.1176/appi.neuropsych.18010011. [Epub ahead of print]

PMID:
30187820
4.

Airway clearance by exercising in mild cystic fibrosis (ACE-CF): A feasibility study.

Ward N, Stiller K, Rowe H, Morrow S, Morton J, Greville H, Holland AE.

Respir Med. 2018 Sep;142:23-28. doi: 10.1016/j.rmed.2018.07.008. Epub 2018 Jul 19.

PMID:
30170797
5.

What are the best societal investments for improving people's health?

Webber L, Chalkidou K, Morrow S, Ferguson B, McPherson K.

BMJ. 2018 Aug 30;362:k3377. doi: 10.1136/bmj.k3377. No abstract available.

PMID:
30166316
6.

Short Report: Prevalence of Cognitive Impairment in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis.

DiGiuseppe G, Blair M, Morrow SA.

Int J MS Care. 2018 Jul-Aug;20(4):153-157. doi: 10.7224/1537-2073.2017-029.

7.

A transient self-assembling self-replicator.

Colomer I, Morrow SM, Fletcher SP.

Nat Commun. 2018 Jun 8;9(1):2239. doi: 10.1038/s41467-018-04670-2.

8.

Methylmercury promotes breast cancer cell proliferation.

Gaudet HM, Christensen E, Conn B, Morrow S, Cressey L, Benoit J.

Toxicol Rep. 2018 May 25;5:579-584. doi: 10.1016/j.toxrep.2018.05.002. eCollection 2018.

9.

Engendering healthy masculinities to prevent sexual violence: Rationale for and design of the Manhood 2.0 trial.

Abebe KZ, Jones KA, Culyba AJ, Feliz NB, Anderson H, Torres I, Zelazny S, Bamwine P, Boateng A, Cirba B, Detchon A, Devine D, Feinstein Z, Macak J, Massof M, Miller-Walfish S, Morrow SE, Mulbah P, Mulwa Z, Paglisotti T, Ripper L, Ports KA, Matjasko JL, Garg A, Kato-Wallace J, Pulerwitz J, Miller E.

Contemp Clin Trials. 2018 Aug;71:18-32. doi: 10.1016/j.cct.2018.05.017. Epub 2018 May 23.

10.

Hyphenation of capillary electrophoresis to inductively coupled plasma mass spectrometry with a modified coaxial sheath-flow interface.

Holtkamp HU, Morrow SJ, Kubanik M, Hartinger CG.

J Chromatogr A. 2018 Aug 3;1561:76-82. doi: 10.1016/j.chroma.2018.05.036. Epub 2018 May 16.

PMID:
29798804
11.

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models.

Ng SY, Yoshida N, Christie AL, Ghandi M, Dharia NV, Dempster J, Murakami M, Shigemori K, Morrow SN, Van Scoyk A, Cordero NA, Stevenson KE, Puligandla M, Haas B, Lo C, Meyers R, Gao G, Cherniack A, Louissaint A Jr, Nardi V, Thorner AR, Long H, Qiu X, Morgan EA, Dorfman DM, Fiore D, Jang J, Epstein AL, Dogan A, Zhang Y, Horwitz SM, Jacobsen ED, Santiago S, Ren JG, Guerlavais V, Annis DA, Aivado M, Saleh MN, Mehta A, Tsherniak A, Root D, Vazquez F, Hahn WC, Inghirami G, Aster JC, Weinstock DM, Koch R.

Nat Commun. 2018 May 22;9(1):2024. doi: 10.1038/s41467-018-04356-9.

12.

Pearls & Oy-sters: An unusual neuropsychiatric manifestation of systemic lupus erythematosus.

Kim DD, Ho C, King R, Morrow SA.

Neurology. 2018 May 22;90(21):e1929-e1932. doi: 10.1212/WNL.0000000000005555. No abstract available.

PMID:
29784725
13.

Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner.

Oh J, Gagné-Brosseau MS, Guenette M, Larochelle C, Lemieux F, Menon S, Morrow SA, Poliquin-Lasnier L, Roy-Hewitson C, Rush C, Trudelle AM, Giacomini PS.

Can J Neurol Sci. 2018 May;45(3):304-312. doi: 10.1017/cjn.2018.7.

PMID:
29756588
14.

Analysis of bystander CPR quality during out-of-hospital cardiac arrest using data derived from automated external defibrillators.

Fernando SM, Vaillancourt C, Morrow S, Stiell IG.

Resuscitation. 2018 Jul;128:138-143. doi: 10.1016/j.resuscitation.2018.05.012. Epub 2018 May 16.

PMID:
29753856
15.

Sequencing of disease-modifying therapies for relapsing-remitting multiple sclerosis: a theoretical approach to optimizing treatment.

Grand'Maison F, Yeung M, Morrow SA, Lee L, Emond F, Ward BJ, Laneuville P, Schecter R.

Curr Med Res Opin. 2018 Aug;34(8):1419-1430. doi: 10.1080/03007995.2018.1458023. Epub 2018 Apr 18.

PMID:
29583054
16.

Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids: A Randomized Clinical Trial.

Morrow SA, Fraser JA, Day C, Bowman D, Rosehart H, Kremenchutzky M, Nicolle M.

JAMA Neurol. 2018 Jun 1;75(6):690-696. doi: 10.1001/jamaneurol.2018.0024.

PMID:
29507942
17.

Metallomic study on the metabolism of RAPTA-C and cisplatin in cell culture medium and its impact on cell accumulation.

Holtkamp HU, Movassaghi S, Morrow SJ, Kubanik M, Hartinger CG.

Metallomics. 2018 Mar 1;10(3):455-462. doi: 10.1039/c8mt00024g. Epub 2018 Feb 27.

PMID:
29484339
18.

Measurements of Multiparticle Correlations in d+Au Collisions at 200, 62.4, 39, and 19.6 GeV and p+Au Collisions at 200 GeV and Implications for Collective Behavior.

Aidala C, Akiba Y, Alfred M, Andrieux V, Aoki K, Apadula N, Asano H, Ayuso C, Azmoun B, Babintsev V, Bagoly A, Bandara NS, Barish KN, Bathe S, Bazilevsky A, Beaumier M, Belmont R, Berdnikov A, Berdnikov Y, Blau DS, Boer M, Bok JS, Brooks ML, Bryslawskyj J, Bumazhnov V, Butler C, Campbell S, Canoa Roman V, Cervantes R, Chi CY, Chiu M, Choi IJ, Choi JB, Citron Z, Connors M, Cronin N, Csanád M, Csörgő T, Danley TW, Daugherity MS, David G, DeBlasio K, Dehmelt K, Denisov A, Deshpande A, Desmond EJ, Dion A, Dixit D, Do JH, Drees A, Drees KA, Dumancic M, Durham JM, Durum A, Elder T, Enokizono A, En'yo H, Esumi S, Fadem B, Fan W, Feege N, Fields DE, Finger M, Finger M, Fokin SL, Frantz JE, Franz A, Frawley AD, Fukuda Y, Gal C, Gallus P, Garg P, Ge H, Giordano F, Goto Y, Grau N, Greene SV, Grosse Perdekamp M, Gunji T, Guragain H, Hachiya T, Haggerty JS, Hahn KI, Hamagaki H, Hamilton HF, Han SY, Hanks J, Hasegawa S, Haseler TOS, He X, Hemmick TK, Hill JC, Hill K, Hodges A, Hollis RS, Homma K, Hong B, Hoshino T, Hotvedt N, Huang J, Huang S, Imai K, Imrek J, Inaba M, Iordanova A, Isenhower D, Ito Y, Ivanishchev D, Jacak BV, Jezghani M, Ji Z, Jiang X, Johnson BM, Jorjadze V, Jouan D, Jumper DS, Kang JH, Kapukchyan D, Karthas S, Kawall D, Kazantsev AV, Khachatryan V, Khanzadeev A, Kim C, Kim DJ, Kim EJ, Kim M, Kim MH, Kincses D, Kistenev E, Klatsky J, Kline P, Koblesky T, Kotov D, Kudo S, Kurita K, Kwon Y, Lajoie JG, Lallow EO, Lebedev A, Lee S, Lee SH, Leitch MJ, Leung YH, Lewis NA, Li X, Lim SH, Liu LD, Liu MX, Loggins VR, Lökös S, Lovasz K, Lynch D, Majoros T, Makdisi YI, Makek M, Malaev M, Manko VI, Mannel E, Masuda H, McCumber M, McGaughey PL, McGlinchey D, McKinney C, Mendoza M, Metzger WJ, Mignerey AC, Mihalik DE, Milov A, Mishra DK, Mitchell JT, Mitsuka G, Miyasaka S, Mizuno S, Montuenga P, Moon T, Morrison DP, Morrow SIM, Murakami T, Murata J, Nagai K, Nagashima K, Nagashima T, Nagle JL, Nagy MI, Nakagawa I, Nakagomi H, Nakano K, Nattrass C, Niida T, Nouicer R, Novák T, Novitzky N, Novotny R, Nyanin AS, O'Brien E, Ogilvie CA, Orjuela Koop JD, Osborn JD, Oskarsson A, Ottino GJ, Ozawa K, Pantuev V, Papavassiliou V, Park JS, Park S, Pate SF, Patel M, Peng W, Perepelitsa DV, Perera GDN, Peressounko DY, PerezLara CE, Perry J, Petti R, Phipps M, Pinkenburg C, Pisani RP, Pun A, Purschke ML, Radzevich PV, Read KF, Reynolds D, Riabov V, Riabov Y, Richford D, Rinn T, Rolnick SD, Rosati M, Rowan Z, Runchey J, Safonov AS, Sakaguchi T, Sako H, Samsonov V, Sarsour M, Sato K, Sato S, Schaefer B, Schmoll BK, Sedgwick K, Seidl R, Sen A, Seto R, Sexton A, Sharma D, Shein I, Shibata TA, Shigaki K, Shimomura M, Shioya T, Shukla P, Sickles A, Silva CL, Silvermyr D, Singh BK, Singh CP, Singh V, Skoby MJ, Slunečka M, Smith KL, Snowball M, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Stankus PW, Stoll SP, Sugitate T, Sukhanov A, Sumita T, Sun J, Syed S, Sziklai J, Takeda A, Tanida K, Tannenbaum MJ, Tarafdar S, Taranenko A, Tarnai G, Tieulent R, Timilsina A, Todoroki T, Tomášek M, Towell CL, Towell RS, Tserruya I, Ueda Y, Ujvari B, van Hecke HW, Vazquez-Carson S, Velkovska J, Virius M, Vrba V, Vukman N, Wang XR, Wang Z, Watanabe Y, Watanabe YS, Wong CP, Woody CL, Xu C, Xu Q, Xue L, Yalcin S, Yamaguchi YL, Yamamoto H, Yanovich A, Yin P, Yoo JH, Yoon I, Yu H, Yushmanov IE, Zajc WA, Zelenski A, Zharko S, Zou L; PHENIX Collaboration.

Phys Rev Lett. 2018 Feb 9;120(6):062302. doi: 10.1103/PhysRevLett.120.062302.

PMID:
29481251
19.

Anti-cholinergic medications for bladder dysfunction worsen cognition in persons with multiple sclerosis.

Morrow SA, Rosehart H, Sener A, Welk B.

J Neurol Sci. 2018 Feb 15;385:39-44. doi: 10.1016/j.jns.2017.11.028. Epub 2017 Nov 22.

PMID:
29406911
20.

Anxiety is more important than depression in MS - Yes.

Morrow SA.

Mult Scler. 2018 Apr;24(4):440-441. doi: 10.1177/1352458517751652. Epub 2018 Jan 30. No abstract available.

PMID:
29381115
21.

Nuclear Dependence of the Transverse-Single-Spin Asymmetry for Forward Neutron Production in Polarized p+A Collisions at sqrt[s_{NN}]=200  GeV.

Aidala C, Akiba Y, Alfred M, Andrieux V, Aoki K, Apadula N, Asano H, Ayuso C, Azmoun B, Babintsev V, Bagoly A, Bandara NS, Barish KN, Bathe S, Bazilevsky A, Beaumier M, Belmont R, Berdnikov A, Berdnikov Y, Blau DS, Boer M, Bok JS, Brooks ML, Bryslawskyj J, Bumazhnov V, Butler C, Campbell S, Canoa Roman V, Cervantes R, Chi CY, Chiu M, Choi IJ, Choi JB, Citron Z, Connors M, Cronin N, Csanád M, Csörgő T, Danley TW, Daugherity MS, David G, DeBlasio K, Dehmelt K, Denisov A, Deshpande A, Desmond EJ, Dion A, Dixit D, Do JH, Drees A, Drees KA, Dumancic M, Durham JM, Durum A, Elder T, Enokizono A, En'yo H, Esumi S, Fadem B, Fan W, Feege N, Fields DE, Finger M, Finger M, Fokin SL, Frantz JE, Franz A, Frawley AD, Fukuda Y, Gal C, Gallus P, Garg P, Ge H, Giordano F, Goto Y, Grau N, Greene SV, Grosse Perdekamp M, Gunji T, Guragain H, Hachiya T, Haggerty JS, Hahn KI, Hamagaki H, Hamilton HF, Han SY, Hanks J, Hasegawa S, Haseler TOS, He X, Hemmick TK, Hill JC, Hill K, Hollis RS, Homma K, Hong B, Hoshino T, Hotvedt N, Huang J, Huang S, Imai K, Imrek J, Inaba M, Iordanova A, Isenhower D, Ito Y, Ivanishchev D, Jacak BV, Jezghani M, Ji Z, Jiang X, Johnson BM, Jorjadze V, Jouan D, Jumper DS, Kang JH, Kapukchyan D, Karthas S, Kawall D, Kazantsev AV, Khachatryan V, Khanzadeev A, Kim C, Kim DJ, Kim EJ, Kim M, Kim MH, Kincses D, Kistenev E, Klatsky J, Kline P, Koblesky T, Kotov D, Kudo S, Kurita K, Kwon Y, Lajoie JG, Lallow EO, Lebedev A, Lee S, Leitch MJ, Leung YH, Lewis NA, Li X, Lim SH, Liu LD, Liu MX, Loggins VR, Lökös S, Lovasz K, Lynch D, Majoros T, Makdisi YI, Makek M, Malaev M, Manko VI, Mannel E, Masuda H, McCumber M, McGaughey PL, McGlinchey D, McKinney C, Mendoza M, Metzger WJ, Mignerey AC, Mihalik DE, Milov A, Mishra DK, Mitchell JT, Mitsuka G, Miyasaka S, Mizuno S, Montuenga P, Moon T, Morrison DP, Morrow SIM, Murakami T, Murata J, Nagai K, Nagashima K, Nagashima T, Nagle JL, Nagy MI, Nakagawa I, Nakagomi H, Nakano K, Nattrass C, Niida T, Nouicer R, Novák T, Novitzky N, Novotny R, Nyanin AS, O'Brien E, Ogilvie CA, Orjuela Koop JD, Osborn JD, Oskarsson A, Ottino GJ, Ozawa K, Pantuev V, Papavassiliou V, Park JS, Park S, Pate SF, Patel M, Peng W, Perepelitsa DV, Perera GDN, Peressounko DY, PerezLara CE, Perry J, Petti R, Phipps M, Pinkenburg C, Pisani RP, Pun A, Purschke ML, Radzevich PV, Read KF, Reynolds D, Riabov V, Riabov Y, Richford D, Rinn T, Rolnick SD, Rosati M, Rowan Z, Runchey J, Safonov AS, Sakaguchi T, Sako H, Samsonov V, Sarsour M, Sato K, Sato S, Schaefer B, Schmoll BK, Sedgwick K, Seidl R, Sen A, Seto R, Sexton A, Sharma D, Shein I, Shibata TA, Shigaki K, Shimomura M, Shioya T, Shukla P, Sickles A, Silva CL, Silvermyr D, Singh BK, Singh CP, Singh V, Skoby MJ, Slunečka M, Smith KL, Snowball M, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Stankus PW, Stoll SP, Sugitate T, Sukhanov A, Sumita T, Sun J, Syed S, Sziklai J, Takeda A, Tanida K, Tannenbaum MJ, Tarafdar S, Taranenko A, Tarnai G, Tieulent R, Timilsina A, Todoroki T, Tomášek M, Towell CL, Towell RS, Tserruya I, Ueda Y, Ujvari B, van Hecke HW, Vazquez-Carson S, Velkovska J, Virius M, Vrba V, Vukman N, Wang XR, Wang Z, Watanabe Y, Watanabe YS, Wong CP, Woody CL, Xu C, Xu Q, Xue L, Yalcin S, Yamaguchi YL, Yamamoto H, Yanovich A, Yin P, Yoo JH, Yoon I, Yu H, Yushmanov IE, Zajc WA, Zelenski A, Zharko S, Zou L; PHENIX Collaboration.

Phys Rev Lett. 2018 Jan 12;120(2):022001. doi: 10.1103/PhysRevLett.120.022001.

PMID:
29376675
22.

Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group.

Members of the MS in the 21st Century Steering Group:, Rieckmann P, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Kesselring J, Kobelt G, Langdon D, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C, Thompson H, Vermersch P, Aston K, Bauer B, Demory C, Giambastiani MP, Hlavacova J, Nouvet-Gire J, Pepper G, Pontaga M, Rogan E, Rogalski C, van Galen P, Ben-Amor AF.

Mult Scler Relat Disord. 2018 Jan;19:153-160. doi: 10.1016/j.msard.2017.11.013. Epub 2017 Nov 21.

23.

Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma.

Horwitz SM, Koch R, Porcu P, Oki Y, Moskowitz A, Perez M, Myskowski P, Officer A, Jaffe JD, Morrow SN, Allen K, Douglas M, Stern H, Sweeney J, Kelly P, Kelly V, Aster JC, Weaver D, Foss FM, Weinstock DM.

Blood. 2018 Feb 22;131(8):888-898. doi: 10.1182/blood-2017-08-802470. Epub 2017 Dec 12.

PMID:
29233821
24.

A pragmatic group sequential, placebo-controlled, randomised trial to determine the effectiveness of glyceryl trinitrate for retained placenta (GOT-IT): a study protocol.

Denison FC, Norrie J, Lawton J, Norman JE, Scotland G, McPherson GC, McDonald A, Forrest M, Hudson J, Brewin J, Peace M, Clarkson C, Brook-Smith S, Morrow S, Hallowell N, Hodges L, Carruthers KF.

BMJ Open. 2017 Sep 18;7(9):e017134. doi: 10.1136/bmjopen-2017-017134.

25.

A Grounded Theory of Sexual Minority Women and Transgender Individuals' Social Justice Activism.

Hagen WB, Hoover SM, Morrow SL.

J Homosex. 2018;65(7):833-859. doi: 10.1080/00918369.2017.1364562. Epub 2017 Sep 22.

PMID:
28825527
26.

A cluster-randomized trial of a middle school gender violence prevention program: Design, rationale, and sample characteristics.

Abebe KZ, Jones KA, Ciaravino S, Ripper L, Paglisotti T, Morrow SE, Grafals M, Van Dusen C, Miller E.

Contemp Clin Trials. 2017 Nov;62:11-20. doi: 10.1016/j.cct.2017.08.007. Epub 2017 Aug 15.

27.

On-road assessment of fitness-to-drive in persons with MS with cognitive impairment: A prospective study.

Morrow SA, Classen S, Monahan M, Danter T, Taylor R, Krasniuk S, Rosehart H, He W.

Mult Scler. 2018 Oct;24(11):1499-1506. doi: 10.1177/1352458517723991. Epub 2017 Aug 7.

PMID:
28782411
28.

Visual Correlates of Fitness to Drive in Adults With Multiple Sclerosis.

Classen S, Krasniuk S, Morrow SA, Alvarez L, Monahan M, Danter T, Rosehart H.

OTJR (Thorofare N J). 2018 Jan;38(1):15-27. doi: 10.1177/1539449217718841. Epub 2017 Aug 2.

PMID:
28766462
29.

Ecotype Variation of Methyl Eugenol Content in Tea Tree (Melaleuca alternifolia and Melaleuca linariifolia).

Shepherd M, Savins D, Dowell A, Morrow S, Allen G, Southwell I.

Chem Biodivers. 2017 Nov;14(11). doi: 10.1002/cbdv.201700278. Epub 2017 Oct 27.

PMID:
28749029
30.

Understanding leisure-time physical activity: Voices of people with MS who have moderate-to-severe disability and their family caregivers.

Fakolade A, Lamarre J, Latimer-Cheung A, Parsons T, Morrow SA, Finlayson M.

Health Expect. 2018 Feb;21(1):181-191. doi: 10.1111/hex.12600. Epub 2017 Jul 19.

31.

Exploring the perspectives of clinical professionals and support staff on implementing supported self-management for asthma in UK general practice: an IMP2ART qualitative study.

Morrow S, Daines L, Wiener-Ogilvie S, Steed L, McKee L, Caress AL, Taylor SJC, Pinnock H.

NPJ Prim Care Respir Med. 2017 Jul 18;27(1):45. doi: 10.1038/s41533-017-0041-y.

32.

Self-reported maximum walking distance in persons with MS may affect the EDSS.

Berger W, Payne MWC, Morrow SA.

J Neurol Sci. 2017 Aug 15;379:77-80. doi: 10.1016/j.jns.2017.05.035. Epub 2017 May 17.

PMID:
28716284
33.

The risk of dementia with the use of 5 alpha reductase inhibitors.

Welk B, McArthur E, Ordon M, Morrow SA, Hayward J, Dixon S.

J Neurol Sci. 2017 Aug 15;379:109-111. doi: 10.1016/j.jns.2017.05.064. Epub 2017 May 31.

PMID:
28716218
34.

Canadian Normative Data for Minimal Assessment of Cognitive Function in Multiple Sclerosis.

Walker LAS, Marino D, Berard JA, Feinstein A, Morrow SA, Cousineau D.

Can J Neurol Sci. 2017 Sep;44(5):547-555. doi: 10.1017/cjn.2017.199. Epub 2017 Jul 7.

PMID:
28683843
35.

Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients.

Eftekhari E, Hojjat SP, Vitorino R, Carroll TJ, Cantrell CG, Lee L, Taylor MW, Morrow SA, Benhabib H, Aviv RI, Kassner A.

Neuroradiology. 2017 Aug;59(8):771-780. doi: 10.1007/s00234-017-1862-7. Epub 2017 Jun 16.

PMID:
28623483
36.

Driving Errors That Predict On-Road Outcomes in Adults With Multiple Sclerosis.

Krasniuk S, Classen S, Morrow SA, Monahan M, Danter T, Rosehart H, He W.

OTJR (Thorofare N J). 2017 May 1:1539449217708554. doi: 10.1177/1539449217708554. [Epub ahead of print]

PMID:
28539098
37.

Transmission of chirality through space and across length scales.

Morrow SM, Bissette AJ, Fletcher SP.

Nat Nanotechnol. 2017 May 5;12(5):410-419. doi: 10.1038/nnano.2017.62. Review.

PMID:
28474691
38.

An optimized method for cryogenic storage of Xenopus sperm to maximise the effectiveness of research using genetically altered frogs.

Pearl E, Morrow S, Noble A, Lerebours A, Horb M, Guille M.

Theriogenology. 2017 Apr 1;92:149-155. doi: 10.1016/j.theriogenology.2017.01.007. Epub 2017 Jan 17.

39.

The effect of Fampridine-SR on cognitive fatigue in a randomized double-blind crossover trial in patients with MS.

Morrow SA, Rosehart H, Johnson AM.

Mult Scler Relat Disord. 2017 Jan;11:4-9. doi: 10.1016/j.msard.2016.10.011. Epub 2016 Nov 4.

PMID:
28104253
40.

Developing easy to perform routine MRI measurements as potential surrogates for cognitive impairment in MS.

Morrow SA, Menon S, Rosehart H, Sharma M.

Clin Neurol Neurosurg. 2017 Feb;153:73-78. doi: 10.1016/j.clineuro.2016.12.015. Epub 2016 Dec 29.

PMID:
28061362
41.

Interrater reliability of Western University's on-road assessment.

Classen S, Krasniuk S, Knott M, Alvarez L, Monahan M, Morrow S, Danter T.

Can J Occup Ther. 2016 Dec;83(5):317-325. doi: 10.1177/0008417416663228.

PMID:
28050933
42.

Cobalt complexes as internal standards for capillary zone electrophoresis-mass spectrometry studies in biological inorganic chemistry.

Holtkamp HU, Morrow SJ, Kubanik M, Hartinger CG.

J Biol Inorg Chem. 2017 Jul;22(5):789-798. doi: 10.1007/s00775-016-1426-z. Epub 2017 Jan 2.

PMID:
28044210
43.

Comparing depression screening tools in persons with multiple sclerosis (MS).

Hanna J, Santo JB, Blair M, Smolewska K, Warriner E, Morrow SA.

Rehabil Psychol. 2017 Feb;62(1):20-24. doi: 10.1037/rep0000115. Epub 2016 Dec 5.

PMID:
27918176
44.

The complexities of power in feminist multicultural psychotherapy supervision.

Arczynski AV, Morrow SL.

J Couns Psychol. 2017 Mar;64(2):192-205. doi: 10.1037/cou0000179. Epub 2016 Dec 5.

PMID:
27918171
45.

Social status alters immune regulation and response to infection in macaques.

Snyder-Mackler N, Sanz J, Kohn JN, Brinkworth JF, Morrow S, Shaver AO, Grenier JC, Pique-Regi R, Johnson ZP, Wilson ME, Barreiro LB, Tung J.

Science. 2016 Nov 25;354(6315):1041-1045.

46.

Educating professionals to support self-management in people with asthma or diabetes: protocol for a systematic review and scoping exercise.

McCleary N, Andrews A, Morrow S, Wiener-Ogilvie S, Fletcher M, Steed L, Taylor SJ, Pinnock H; IMP2ART team.

BMJ Open. 2016 Oct 28;6(10):e011937. doi: 10.1136/bmjopen-2016-011937. Review.

47.

Development and Validity of Western University's On-Road Assessment.

Classen S, Krasniuk S, Alvarez L, Monahan M, Morrow SA, Danter T.

OTJR (Thorofare N J). 2017 Jan;37(1):14-29. doi: 10.1177/1539449216672859. Epub 2016 Oct 15.

PMID:
27744272
48.

Effects of freezing and activation on membrane quality and DNA damage in Xenopus tropicalis and Xenopus laevis spermatozoa.

Morrow S, Gosálvez J, López-Fernández C, Arroyo F, Holt WV, Guille MJ.

Reprod Fertil Dev. 2017 Aug;29(8):1556-1566. doi: 10.1071/RD16190.

PMID:
27692061
49.

Stories of People Who Have Attended a Lesbian, Gay, Bisexual and Trans Support Group in a Secure Intellectual Disability Service.

Tallentire L, Smith M, David L, Roberts A, Bruce, Morrow S, Withers P, Smith I.

J Appl Res Intellect Disabil. 2016 Aug 31. doi: 10.1111/jar.12281. [Epub ahead of print]

PMID:
27576912
50.

Association Between Gadolinium Contrast Exposure and the Risk of Parkinsonism.

Welk B, McArthur E, Morrow SA, MacDonald P, Hayward J, Leung A, Lum A.

JAMA. 2016 Jul 5;316(1):96-8. doi: 10.1001/jama.2016.8096. No abstract available.

PMID:
27380348

Supplemental Content

Loading ...
Support Center